If all medical institutions around the world inhale vapor that is inevitably leaked and exposed while preparing strong anticancer drugs with syringes, it is difficult to avoid preparing anticancer drugs and inject anticancer drugs safely in a short period of time. An alternative has been developed, but it is used only in some countries, including Korea, where patients are concentrated in large hospitals due to low cost and narrow preparation ranges, and almost all countries around the world do not adopt it, and most global buyers do not know it.

HIS-linked automatic Anyfusion ACPI system and semi-automatic Anyfusion ACPI system have added information on price-performance and practical Anyfusion ACPI system with a high daily dose of 300 to 400 cases and a wide range of 90% or more.

In addition, because robot equipment is expensive, it is used only in 28 countries with high national income, and when extracting drugs from anticancer drugs and introducing them into formulation containers, the risk of contamination is blocked by offsetting negative pressure, minimizing leakage and exposure.

In addition, 1) all expensive anticancer drugs can be extracted from the container, 2) the optimal amount can be injected into the powder-sanctioned container, and 3) CSTD made of plastic material comes off the rubber cap when punching to the Vial or Bottle container, but MCST1 is complementary, safe, and reasonable.

We also added MCST1 to the homepage.

Remove air from the infusion tube line used in Anyfusion pumps or conventional pumps by priming through drugs or nutritional supplements

In order to remove air from the tube line, it is inevitable to dispose of it on the floor of the hospital room, garbage cans, and sewage facilities while passing more than a certain amount of drugs or nutritional supplements.

It runs counter to the clean room environment, which must be kept sterile for the safety of patients as well as the loss of expensive drugs or nutrients, and can cause bacterial growth, and is a factor that overloads the nurse's workload.

MCST2, developed and patented by Meinntech, is an innovative technology that can solve these problems that have been overlooked so far, and reduce safe patient treatment and nursing work by minimizing the risk of hospital infection.

It is expected to be the next flagship product of Meinntech and we would like to foster it.

We are not good enough, but we will update the upgraded version of the product based on the information obtained from real world.

Thank you.